Skip to main content
Search
Home    /    Insights & Resources

Insights & Resources

Start exploring insights from across the industries we serve, featuring the latest industry trends, compliance alerts, tax and accounting news and much more.

With the current interest rate and economic development, financial institutions may need to review their risk management strategies and practices.
Many businesses face challenges such as cost, inefficiency and potential fraud when invoicing manually. Learn about the benefits of e-invoicing.
Payment fraud is a big business and it will continue to be a key risk facing organizations for the foreseeable future. Learn how to prevent it.
U.S. banking regulatory agencies (including the Federal Reserve, FDIC & OCC) released their first-ever joint statement on crypto-asset risks to banking organizations.
The Inflation Reduction Act includes a Greenhouse Gas Reduction act that can be accessed through green banks, which play an important role in funding environmental initiatives.
Find out why green banks offer excellent opportunities for financing clean energy projects in both the public and private sectors.
Landing a corporate sponsorship is an accomplishment, especially in today’s economy. If you do succeed in securing a corporate sponsorship, you’ll want to keep unrelated business income tax (UBIT) from cutting into your new income.
With the release of the “Pandora Papers,” there is renewed attention on transparency in corporate ownership.
Last week, the FFIEC issued a Joint Statement on Managing the LIBOR Transition, which highlighted risks associated with the discontinuation of LIBOR as well as supervisory expectations around this transition.
When cryptocurrencies first came on the scene, they were widely viewed as a fringe development, but in recent years they’ve moved closer to the mainstream.
On July 29, 2021 the Federal Deposit Insurance Corporation (FDIC) released Answers to Frequently Asked Questions about the Impact of London Interbank Offered Rate (LIBOR) Transitions on Regulatory Capital Instruments.
1 2 3 4 5 7